C

CNS Pharmaceuticals
D

CNSP

3.25000
USD
3.18
(4,268.28%)
مغلق
حجم التداول
23,701
الربح لكل سهم
-14
العائد الربحي
-
P/E
0
حجم السوق
4,872,563
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    1.200
    (0.60%)
    202.140 USD
    AZN
    AZN
    -0.350
    (-0.47%)
    74.220 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    C
    CRVS
    -0.22000
    (-4.99%)
    4.19000 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    المزيد
الأخبار
المقالات

العنوان: CNS Pharmaceuticals Inc.

القطاع: Healthcare
الصناعة: Biotechnology
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.